Preexisting Cardiovascular Disease, Hypertension, and Mortality in Peritoneal Dialysis

Juan Wu1, Xiaojiang Zhan2, Yueqiang Wen3

  • 1Urology & Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), 310014 Hangzhou, Zhejiang, China.

Insights

Preexisting cardiovascular disease (CVD) and hypertension significantly increase mortality risk in peritoneal dialysis (PD) patients. The combination of both conditions poses the highest mortality risk, highlighting their additive prognostic impact.

Area of Science:

  • Nephrology and Cardiovascular Medicine
  • Epidemiology and Public Health

Background:

  • Cardiovascular disease (CVD) and hypertension are known risk factors for poor outcomes in peritoneal dialysis (PD) patients.
  • The combined prognostic impact of preexisting CVD and hypertension in PD patients requires further comprehensive evaluation.

Purpose of the Study:

  • To investigate the joint associations between preexisting cardiovascular disease (CVD), hypertension, and mortality in incident peritoneal dialysis (PD) patients.
  • To determine the independent and combined prognostic significance of CVD and hypertension on all-cause and CVD-specific mortality in PD.

Main Methods:

  • Retrospective cohort study involving 3073 incident PD patients from five Chinese dialysis centers (2005-2018).
  • Cox regression models and Fine-Gray competing risk models were used to analyze the associations between preexisting CVD, hypertension, and mortality outcomes.
  • Adjustments were made for relevant confounding factors to isolate the impact of CVD and hypertension.

Main Results:

  • Over a median follow-up of 33.7 months, 18.6% of patients died, with 9.3% due to CVD.
  • Patients with both preexisting CVD and hypertension had the highest risk of all-cause mortality (HR: 3.97) and CVD mortality (HR: 4.68) compared to controls.
  • Individually, preexisting CVD (HR: 2.21 for all-cause mortality) and hypertension (HR: 1.83 for all-cause mortality) also significantly increased mortality risk.

Conclusions:

  • Preexisting cardiovascular disease and hypertension have additive prognostic value for mortality in PD patients.
  • Preexisting CVD demonstrates a stronger association with mortality risk than hypertension in this PD population.
  • These findings underscore the importance of managing cardiovascular risk factors in PD patients to improve survival outcomes.
Abstract

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
286
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.1K
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
539